Table 2.
Nanomaterial | Pros | Cons | References |
---|---|---|---|
MNPs/nanoclusters | Biocompatibility, magnetic separation, high sensitivity | Magnetic aggregation; dependence on binding capacity of MNPs (affinity-based) | 42, 109–112 |
Fe-core MNPs | High magnetic moments, superparamagnetic | Rapid oxidation → protective shells needed | 57 |
Magnetic–optical bifunctional NPs | Simultaneous detection and isolation of various tumor-cell types, killing by X-ray-based detection possible | Affinity-based | 53 |
Micro-NMR | Rapid, highly sensitive biomarker detection, only minimal sample purification necessary | Variation in NMR frequency depending on temperature | 57 |
Quantum dots | Quantitative detection with high sensitivity, various fluorescence types enable capture of heterogeneous CTCs | Toxicity affects viability (no further investigations possible), intermittence under continuous excitation | 21, 53 |
Gold NPs | Microsurgical removal/laser-controlled detection and direct ablation of CTCs, postcapture analysis | Nonbiodegradability, complicated preparation | 21, 53, 113, 114 |
Graphene/graphene oxides | High specificity, multiplex functionalization, label-free detection, high conductivity, no toxicity, easy functionalization | Aspecific cellular internalization, hybrid sensors not reproducible yet | 21, 53, 92, 115–118 |
Liposomes | Biocompatibility, long blood-circulation time | Low stability | 21, 119, 120 |
Polymeric nanomaterials | Biocompatibility and biodegradability, ease of chemical modification, drug encapsulation/conjugation, improves sensitivity/selectivity of surfaces for CTC detection | Low stability | 53, 97, 121 |
Hybrid NPs | Recovery of viable cells, can proliferate in vitro | Different hybrid NPs for different types of CTCs necessary, all trials still in vitro | 100 |
SWCNTs/MWCNTs | High stability, bioactivity, capable of cell capture, high sensitivity, even in whole blood | One type of aptamer binds only one specific target | 122 |
Microfabricated filters | Label-free, unbiased | Sensitivity to size | 12, 42 |
Microfluidic-enabled immunoseparation | High efficiency, sensitivity, throughput, automatic, further molecular analysis | Relied on microscopy imaging for CTC identification after isolation | 12, 36, 42, 65, 123 |
Herringbone chip | Transparent device for better imaging | 12, 36, 116 | |
CTC chip | High throughput, combination of immunomagnetic sorting with micropost-based enrichment | 12, 36, 116, 124 | |
Micro–Hall detector | Rapid detection, high contrast against blood cells, detection of multiple biomarkers | Limited throughput (about 107 cells) | 124, 125 |
Gilupi nanodetector | Large volume analyzed | Affinity-based, complex procedure | 12, 36 |
Note: Data from Zhang and King.21
Abbreviations: MNPs, magnetic nanoparticles; CTC, circulating tumor cell; SWCNTs, single-walled carbon nanotubes; MWCNTs, multiwalled CNTs; NMR, nuclear magnetic resonance; NP, nanoparticle.